2 citations
,
April 2024 in “European Journal of Dermatology” In this study, researchers analyzed data from Spain to find that alopecia areata is more prevalent in adults, with a point prevalence of 0.44% in 2021; they also noted significant healthcare costs and comorbidities, highlighting an unmet treatment need given limited systemic treatment use.
March 2026 in “Diabetes Obesity and Metabolism” This study reports that from 1990 to 2023, Saudi Arabia experienced a 117.3% increase in age-standardised diabetes prevalence, primarily due to type 2 diabetes mellitus, with projections indicating continued growth in prevalence and disability, despite forecasted reductions in diabetes-related mortality by 2030.
23 citations
,
December 2023 in “Skin Health and Disease” This study highlights a scarcity of data and treatment guidelines for vitiligo in Africa, the Middle East, and Latin America, emphasizing the need for regional epidemiological studies and tailored management approaches.
February 2026 in “Psycho-Oncologie” This narrative review highlights that alopecia areata significantly impacts the psychological wellbeing of cancer patients, contributing to distress, anxiety, and depression, and underscores the importance of integrating dermatologic care with psycho-oncology to improve patient outcomes.
1 citations
,
April 2021 in “Nepal journal of dermatology, venereology & leprology” This study found that the pattern of skin diseases in Kathmandu is evolving, with an increase in allergic and immunologic conditions and a continued prevalence of infections.
